Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AT-1501 in Islet Cell Transplant for Brittle T1D
NCT05480657Phase 2Withdrawn
- Sponsor
- Eledon Pharmaceuticals, Inc.
- Start
- Sep 2022
- Primary completion
- Aug 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of tegoprubart in type 1 diabetes mellitus (T1D), sponsored by Eledon Pharmaceuticals, Inc.. Planned start Sep 2022; status: withdrawn.
02
Drugs
tegoprubart
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT05480657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05480657.